GENOMATE HEALTH, INC. logo
SEC Form D filing

GENOMATE HEALTH, INC.

Health tech · Series A · Regulation D 506(b) · MA · Filed March 12, 2025

Offering amount
$2.0M
Exemption
Reg D 506(b)
Issuer state
MA
Filing date
March 12, 2025
Signature date
CIK
0002056014

Summary

Genomate Health genetic testing platform; $2M series-a healthtech venture.

Source

FormDFlow indexes public-disclosure data from SEC EDGAR. Nothing on this page is investment advice.